Lava Therapeutics Nv Stock Market Value
| LVTX Stock | USD 1.60 0.05 3.23% |
| Symbol | LAVA |
LAVA Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LAVA Therapeutics. If investors know LAVA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LAVA Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Revenue Per Share 0.274 | Quarterly Revenue Growth 4.712 | Return On Assets (0.16) | Return On Equity (0.45) |
The market value of LAVA Therapeutics is measured differently than its book value, which is the value of LAVA that is recorded on the company's balance sheet. Investors also form their own opinion of LAVA Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is LAVA Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LAVA Therapeutics' market value can be influenced by many factors that don't directly affect LAVA Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LAVA Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if LAVA Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LAVA Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LAVA Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LAVA Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LAVA Therapeutics.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in LAVA Therapeutics on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding LAVA Therapeutics NV or generate 0.0% return on investment in LAVA Therapeutics over 30 days. LAVA Therapeutics is related to or competes with Anebulo Pharmaceuticals, Pmv Pharmaceuticals, Bionomics, Edgewise Therapeutics, Ikena Oncology, Design Therapeutics, and Xilio Development. LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments More
LAVA Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LAVA Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LAVA Therapeutics NV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 28.03 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 5.49 |
LAVA Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LAVA Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LAVA Therapeutics' standard deviation. In reality, there are many statistical measures that can use LAVA Therapeutics historical prices to predict the future LAVA Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LAVA Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LAVA Therapeutics Backtested Returns
At this stage we consider LAVA Stock to be risky. LAVA Therapeutics has Sharpe Ratio of 0.0269, which conveys that the company had a 0.0269% return per unit of standard deviation over the last 3 months. We have found twenty-four technical indicators for LAVA Therapeutics, which you can use to evaluate the volatility of the entity. Please verify LAVA Therapeutics' standard deviation of 4.23, and Mean Deviation of 3.09 to check out if the risk estimate we provide is consistent with the expected return of 0.11%. LAVA Therapeutics has a performance score of 2 on a scale of 0 to 100. The firm secures a Beta (Market Risk) of 1.74, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LAVA Therapeutics will likely underperform. LAVA Therapeutics currently secures a risk of 4.05%. Please verify LAVA Therapeutics NV rate of daily change, and the relationship between the kurtosis and market facilitation index , to decide if LAVA Therapeutics NV will be following its current price movements.
Auto-correlation | 0.06 |
Virtually no predictability
LAVA Therapeutics NV has virtually no predictability. Overlapping area represents the amount of predictability between LAVA Therapeutics time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LAVA Therapeutics price movement. The serial correlation of 0.06 indicates that barely 6.0% of current LAVA Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
LAVA Therapeutics lagged returns against current returns
Autocorrelation, which is LAVA Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting LAVA Therapeutics' stock expected returns. We can calculate the autocorrelation of LAVA Therapeutics returns to help us make a trade decision. For example, suppose you find that LAVA Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
LAVA Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If LAVA Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if LAVA Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in LAVA Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
LAVA Therapeutics Lagged Returns
When evaluating LAVA Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of LAVA Therapeutics stock have on its future price. LAVA Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, LAVA Therapeutics autocorrelation shows the relationship between LAVA Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in LAVA Therapeutics NV.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LAVA Stock Analysis
When running LAVA Therapeutics' price analysis, check to measure LAVA Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LAVA Therapeutics is operating at the current time. Most of LAVA Therapeutics' value examination focuses on studying past and present price action to predict the probability of LAVA Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LAVA Therapeutics' price. Additionally, you may evaluate how the addition of LAVA Therapeutics to your portfolios can decrease your overall portfolio volatility.